Solving the Challenges of Adaptive Clinical Trials: Web Seminar Will Reveal Universal, Risk-Resistant Methods for Improving Study Efficiency
Health Decisions and the Center for Business Intelligence present the webinar "Solving the Challenges of Clinical Trials," which will be held Wednesday, October 28 from 11:00 am to noon EDT. Health Decisions is also holding a weekly drawing for free registration passes (a value of $295). To enter, visit http://www.HealthDec.com/page/webinar.
Durham, NC, October 09, 2009 --(PR.com)-- "Every clinical trial can take advantage of adaptive methods," says Dr. Michael Rosenberg, founder, president and CEO of Health Decisions, a full-service CRO specializing in adaptive solutions.
Rosenberg, who will lead a webinar later this month titled "Solving the Challenges of Adaptive Clinical Trials: The keys to improving efficiency for every study," says that all drug developers can achieve timelines shortened by as much 40 percent by gaining a full understanding of adaptive techniques and how to strategically and responsibly employ them.
Produced by The Center for Business Intelligence (CBI Research, Inc., www.cbinet.com) as part of its interactive web seminar series, "Solving the Challenges of Adaptive Clinical Trials" will present solutions to the major obstacles barring most clinical programs from the full benefits of adaptive research methods. Rosenberg, whose 20 years experience developing innovation in clinical trials will provide the basis for the solutions discussed, will be joined by Anthony Cunningham, Health Decisions Manager of Clinical Affairs, who will address the implementation of these solutions on a practical level.
"Solving the Challenges of Adaptive Clinical Trials" will be held on Wednesday, October 28 from 11:00 am to noon EDT. Health Decisions is offering free registration leading up the event through a weekly drawing (a $295 value). To enter, visit http://www.HealthDec.com/page/webinar.
Webinar Abstract and Overview:
Adaptive methods are becoming an increasingly hot topic as clinical research evolves toward a more continuous, efficient path from safety testing through regulatory approval. But without air-tight planning, meticulous management, and a solid understanding of when, how, and under what circumstances to adapt, these techniques can pose more of a risk than a solution — either by damaging data integrity, putting patients at risk, or severely jeopardizing trial timelines and budgets.
There are several ways to successfully adapt clinical trials of all types — regardless of size, complexity, or therapeutic area. This session will discuss best practices for implementing the right kinds of adaptations strategically and responsibly, resulting in faster, more efficient trials and a sharper competitive edge.
Key Learning Points:
- Identify adaptive design strategies, the rules for executing them successfully, and how to determine when they’re appropriate
- Discover the impact of applying adaptive methodology to trial operations
- Plan the best mix of operational and statistical adaptive strategies for your trials’ specific needs
- Learn the key components necessary for success from both a theoretical and practical point of view
- Engage adaptive methods to improve the most common sources of inefficiency in clinical trials: enrollment, query management, monitoring and database lock
- Learn what to require in a trial management platform and data capture tools
To register, visit CBI Research, Inc. online at http://www.cbinet.com/webinars/showWebinar.cfm?confCode=EC09096
For more information, please contact Katie Hendrick, Marketing Specialist, by email at khendrick@HealthDec.com or by phone at +1.919.967.1111 x116.
About Health Decisions
Health Decisions (www.HealthDec.com)is a full-service, global clinical research organization (CRO) specializing in high-efficiency adaptive solutions. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10-40 percent faster than traditional approaches.
Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical drug and device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company’s website at www.HealthDec.com.
###
Rosenberg, who will lead a webinar later this month titled "Solving the Challenges of Adaptive Clinical Trials: The keys to improving efficiency for every study," says that all drug developers can achieve timelines shortened by as much 40 percent by gaining a full understanding of adaptive techniques and how to strategically and responsibly employ them.
Produced by The Center for Business Intelligence (CBI Research, Inc., www.cbinet.com) as part of its interactive web seminar series, "Solving the Challenges of Adaptive Clinical Trials" will present solutions to the major obstacles barring most clinical programs from the full benefits of adaptive research methods. Rosenberg, whose 20 years experience developing innovation in clinical trials will provide the basis for the solutions discussed, will be joined by Anthony Cunningham, Health Decisions Manager of Clinical Affairs, who will address the implementation of these solutions on a practical level.
"Solving the Challenges of Adaptive Clinical Trials" will be held on Wednesday, October 28 from 11:00 am to noon EDT. Health Decisions is offering free registration leading up the event through a weekly drawing (a $295 value). To enter, visit http://www.HealthDec.com/page/webinar.
Webinar Abstract and Overview:
Adaptive methods are becoming an increasingly hot topic as clinical research evolves toward a more continuous, efficient path from safety testing through regulatory approval. But without air-tight planning, meticulous management, and a solid understanding of when, how, and under what circumstances to adapt, these techniques can pose more of a risk than a solution — either by damaging data integrity, putting patients at risk, or severely jeopardizing trial timelines and budgets.
There are several ways to successfully adapt clinical trials of all types — regardless of size, complexity, or therapeutic area. This session will discuss best practices for implementing the right kinds of adaptations strategically and responsibly, resulting in faster, more efficient trials and a sharper competitive edge.
Key Learning Points:
- Identify adaptive design strategies, the rules for executing them successfully, and how to determine when they’re appropriate
- Discover the impact of applying adaptive methodology to trial operations
- Plan the best mix of operational and statistical adaptive strategies for your trials’ specific needs
- Learn the key components necessary for success from both a theoretical and practical point of view
- Engage adaptive methods to improve the most common sources of inefficiency in clinical trials: enrollment, query management, monitoring and database lock
- Learn what to require in a trial management platform and data capture tools
To register, visit CBI Research, Inc. online at http://www.cbinet.com/webinars/showWebinar.cfm?confCode=EC09096
For more information, please contact Katie Hendrick, Marketing Specialist, by email at khendrick@HealthDec.com or by phone at +1.919.967.1111 x116.
About Health Decisions
Health Decisions (www.HealthDec.com)is a full-service, global clinical research organization (CRO) specializing in high-efficiency adaptive solutions. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10-40 percent faster than traditional approaches.
Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical drug and device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company’s website at www.HealthDec.com.
###
Contact
Health Decisions
Katie Hendrick, Marketing Specialist
919-960-1111x116
www.HealthDec.com
Contact
Katie Hendrick, Marketing Specialist
919-960-1111x116
www.HealthDec.com
Categories